Eli Lilly Acquires AtaiBeckley for $2.8 Billion

Eli Lilly is set to acquire AtaiBeckley for $2.8 billion, a move that has drawn attention from investors like Cathie Wood, who suggests another psychedelic drug stock might be a better investment.